Swiss - Prancis - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - imatinibum - comprimés pelliculés (sécables) - imatinibum 400 mg ut imatinibi mesilas, cellulosum microcristallinum, crospovidonum, hypromellosum, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, e 172 (flavum), e 172 (rubrum), macrogolum 4000, talcum, pro compresso obducto. - cytostatique; ph+ la leucémie myéloïde chronique (lmc ph+); ph+ la leucémie aiguë lymphoblastique (lal ph+); hypereosinophilensyndrom (she/lce); atypiques myelodysplastische/troubles myéloprolifératifs (smd/smp); mastocytose systémique agressive (aggr. sm); tumeurs stromales gastro-intestinales (gist); dermatofibrosarkom protuberans (dfsp); (pour plus d'informations sur l'indication, voir le résumé des caractéristiques du produit) - synthetika

Swiss - Prancis - Swissmedic (Swiss Agency for Therapeutic Products)

streuli pharma ag - amlodipinum - comprimés - amlodipinum 5 mg à amlodipini mesilas monohydricus, excipiens pro compresso. - calciumantagonist - synthetika

Swiss - Prancis - Swissmedic (Swiss Agency for Therapeutic Products)

streuli pharma ag - amlodipinum - comprimés - amlodipinum 10 mg à amlodipini mesilas monohydricus, excipiens pro compresso. - calciumantagonist - synthetika

Swiss - Prancis - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - amlodipinum - comprimés - amlodipinum 5 mg à amlodipini mesilas monohydricus, cellulosum microcristallinum, calcium hydrogenophosphas, carboxymethylamylum natricum un, de magnésium stearas, pour compresso corresp. sodium 0,17 mg. - calciumantagonist - synthetika

Swiss - Prancis - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - amlodipinum - comprimés - amlodipinum 10 mg à amlodipini mesilas monohydricus, cellulosum microcristallinum, calcium hydrogenophosphas, carboxymethylamylum natricum un, de magnésium stearas, excipiens pro compresso corresp. sodium 0,34 mg. - calciumantagonist - synthetika

Swiss - Prancis - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - eprosartanum - comprimés pelliculés - eprosartanum 600 mg ut eprosartani mesilas, cellulosum microcristallinum, lactosum monohydricum 43.3 mg, amylum pregelificatum, crospovidonum, magnesii stearas, aqua purificata, Überzug: hypromellosum, macrogolum 400, polysorbatum 80, e 171, pro compresso obducto. - hypertonie - synthetika

Swiss - Prancis - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - eprosartanum, hydrochlorothiazidum - comprimés pelliculés - eprosartanum 600 mg ut eprosartani mesilas, hydrochlorothiazidum 12.5 mg, cellulosum microcristallinum, lactosum monohydricum 43.3 mg, amylum pregelificatum, crospovidonum, magnesii stearas, aqua purificata, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (flavum), e 172 (nigrum), pro compresso obducto. - hypertonie - synthetika

Swiss - Prancis - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - trimipraminum - gouttes - trimipraminum 40 mg ut trimipramini mesilas, arom.: ethylvanillinum, vanillinum et alia, color.: e 150(a), excipiens ad solutionem pro 1 ml corresp. 40 guttae corresp. ethanolum 11 % v/v. - antidepressivum - synthetika

Swiss - Prancis - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - trimipraminum - solution buvable en gouttes - trimipraminum 40 mg ut trimipramini mesilas, polysorbatum 80, natrii laurilsulfas corresp. natrium max. 0.1994 mg, ethanolum 96 per centum 100 mg, menthae piperitae aetheroleum, aqua purificata, ad solutionem pro 1 ml corresp. ethanolum 12 % v/v. - antidepressivum - synthetika

Swiss - Prancis - Swissmedic (Swiss Agency for Therapeutic Products)

mylan pharma gmbh - imatinibum - comprimés pelliculés - imatinibum 100 mg ut imatinibi mesilas 119.5 mg, silica colloidalis anhydrica, cellulosum microcristallinum, crospovidonum, hypromellosum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172, pro compresso obducto. - onkologikum - synthetika